Vanguard Capital Management’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
Other funds holding RCKT
NM
Vanguard Capital Management's RCKT Position: Q3 2026 in Review
Vanguard Capital Management increased its Rocket Pharmaceuticals (RCKT) stake by 1.2% in Q3 2026, buying an estimated $160K and bringing the position to 3,830,455 shares worth $10.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2750.
Vanguard Capital Management first reported a position in RCKT in Q1 2026 and has held it in 3 quarters since. The position peaked at $13.5M in Q1 2026. 175 funds tracked by Wall St. Rank hold RCKT as of Q3 2026.
- Vanguard Capital Management held 3,830,455 shares of Rocket Pharmaceuticals worth $10.1M as of Q3 2026.
- Vanguard Capital Management bought 46,068 Rocket Pharmaceuticals shares in Q3 2026, an estimated $160K.
- Rocket Pharmaceuticals made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #2750 holding.
- Vanguard Capital Management first reported a position in Rocket Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
- Vanguard Capital Management's Rocket Pharmaceuticals position peaked at $13.5M in Q1 2026.
- 175 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.